Skip to Main Content

Vishwa Deep Dixit, DVM, PhD - Thermogenic Checkpoints of Weight Loss

March 07, 2024
  • 00:00So next, it's my pleasure to
  • 00:03introduce Doctor Deep Dixit,
  • 00:04who studied veterinary medicine
  • 00:06in India and did his PhD research
  • 00:08at the University of Hanover,
  • 00:09Germany, and postdoctoral research
  • 00:11at Morehouse School of Medicine,
  • 00:13Atlanta and the National Institutes
  • 00:15of On Aging in Baltimore.
  • 00:18He currently holds the Valdemar von
  • 00:21Zewitz Endowed Chair and is the professor
  • 00:23in the Department of Pathology,
  • 00:26Comparative Medicine and
  • 00:27Immunobiology at Yale University.
  • 00:30Doctor Dixit is also the director of
  • 00:32the Yale Center for Research on Aging,
  • 00:35or Y age, at Yale School of Medicine.
  • 00:41Doctor Dixit,
  • 00:46thank you. Thank you, Anya.
  • 00:48You know, it's always the hardest
  • 00:49thing to do is to give a talk,
  • 00:51intramural talk, in a Yale symposium
  • 00:54among the audience from Yale.
  • 00:55Because it's the hardest
  • 00:57because everybody's so great.
  • 00:59So let me see if I can do justice to it.
  • 01:02Now I think we've heard about obesity
  • 01:04and we'll talk more about obesity.
  • 01:05But I just want to remind those of you who
  • 01:08don't think about this as much as we do,
  • 01:11which is that if you compare the
  • 01:14risk factors of various situations
  • 01:17that we are dealing with in life,
  • 01:19actually aging, just getting old,
  • 01:22the process of getting old is
  • 01:24the single biggest risk factor
  • 01:26for each one of these diseases,
  • 01:29including heart disease,
  • 01:30Alzheimer's and cancers.
  • 01:32And this is something that
  • 01:34we're extremely interested in.
  • 01:35And what we are also extremely
  • 01:38interested in is the interaction
  • 01:40that occurs between development of
  • 01:44obesity and chronic obesity that
  • 01:48spills into age as we get older.
  • 01:51So these are data from CDC and
  • 01:53you can see that individuals that
  • 01:57are older adults that are between
  • 02:00the ages of 65 and 74,
  • 02:02in this case the the incidence
  • 02:04of obesity is fairly high,
  • 02:06almost 40% of older adults have obesity.
  • 02:10And what in terms of mechanisms,
  • 02:12we know very little about how
  • 02:15the basic biology of aging and
  • 02:19the aging processes are impacted
  • 02:22when we have this chronic obesity
  • 02:24that is present in aging.
  • 02:26There are some studies,
  • 02:28including some from Yale.
  • 02:30But what's very intriguing is this
  • 02:34response that you see in all 'cause
  • 02:37mortality and the BMI with age, right.
  • 02:40So it's a paradox.
  • 02:42So you will notice that on the Y axis,
  • 02:45this is the mortality hazard
  • 02:47ratio and the BMI listed here
  • 02:49that if as we get older and the
  • 02:51chances of mortality increases.
  • 02:53If the BMI is high,
  • 02:55obviously that is expected.
  • 02:57But also the chances of mortality
  • 03:00are much higher if the BMI is on
  • 03:03the lower end of the spectrum.
  • 03:05How these things are actually mechanistically
  • 03:08related are not very well known.
  • 03:11It's also not known whether you know the
  • 03:17point of time. But it's also well
  • 03:20not known whether if one carries on
  • 03:22obesity and aging risk all this way,
  • 03:25whether this is already a fait accompli,
  • 03:27Is there anything we can do to this
  • 03:30process that would enhance our health?
  • 03:32So we have been interested in
  • 03:34negative energy balance and how
  • 03:36to induce negative energy balance
  • 03:38and what that does to Physiology.
  • 03:40And as Tomas had mentioned,
  • 03:43one of the key interventions that
  • 03:45was discovered almost 100 years
  • 03:48ago that extends lifespan and
  • 03:50health span is caloric restriction.
  • 03:52And so as you know obesity is a
  • 03:57fundamental disorder of thermodynamics.
  • 03:59So you have energy intake and you
  • 04:01have energy out energy expenditure.
  • 04:03We heard a lot about everything
  • 04:05that's currently is known about
  • 04:07obesity interventions,
  • 04:08pharmacologic interventions are
  • 04:09all on energy intake which is
  • 04:12inhibiting your food intake.
  • 04:13And we are very much interested to see
  • 04:15what's the other side of the axis,
  • 04:17Is there a way to expend energy?
  • 04:20Anyway,
  • 04:20I'm not going to go into the details of this,
  • 04:22but we know that when the host
  • 04:24is in negative energy balance,
  • 04:26you get lifespan extension.
  • 04:27Actually you have less diseases,
  • 04:29except there's a dirty little secret here,
  • 04:32which is as we get this longevity,
  • 04:35this longevity dividend comes at
  • 04:39with the risks of these trade-offs.
  • 04:44So animal models that live long,
  • 04:47all of them, they live,
  • 04:48they do live long, but they have,
  • 04:50they're growth ******** they do not breed.
  • 04:53If you take them out from a specific
  • 04:55pathogen free facility, they fall dead.
  • 04:58And we've been studying
  • 04:59this for almost 100 years.
  • 05:00And the question has been if this
  • 05:02intervention that extends lifespan
  • 05:04has this multiple health benefits.
  • 05:06If are we going to ever harness any of
  • 05:08the so-called Pella restriction mimetics?
  • 05:10Is it actually relevant to human Physiology?
  • 05:13And this is what we have been trying
  • 05:15to do over the past 15 years or so.
  • 05:17I'm not going to go into the
  • 05:18details of model organisms.
  • 05:20Both Tomas and I are failed veterinarians.
  • 05:21It's very nice to give a
  • 05:23talk right after him. So.
  • 05:26But the idea here is that the
  • 05:30dietary interventions,
  • 05:31especially things like caloric restriction,
  • 05:33if you do in animals, you know,
  • 05:36animal in a cage does not sign consent forms.
  • 05:39It doesn't know if you're going to,
  • 05:41you know, give 40% less calories.
  • 05:43Animal doesn't know what's going to happen.
  • 05:45So the idea is to actually do a
  • 05:47randomized controlled study in people,
  • 05:48see if it is relevant to human Physiology in
  • 05:50in terms of inducing negative energy balance,
  • 05:53most importantly without
  • 05:54inducing these trade-offs.
  • 05:56And many of these trade-offs
  • 05:57actually come from stress signaling.
  • 05:59All right.
  • 05:59And see if that is actually relevant.
  • 06:01Can we harness those endogenous factors
  • 06:04assigned causality using the animal models?
  • 06:06And this was a trial that was funded
  • 06:08by the National Institute on Aging.
  • 06:10It's now complete.
  • 06:11This trial was initiated while I
  • 06:14was starting my faculty position
  • 06:16in Pennington in Louisiana.
  • 06:17And the idea that NIH wanted was
  • 06:19that we take healthy people, OK?
  • 06:21See,
  • 06:22if we restrict the calories
  • 06:24by 25% for two years,
  • 06:26would that delay the trajectory
  • 06:29of reducing the risk of disease
  • 06:31and slowing the process of aging?
  • 06:35It was a really an ambitious goal
  • 06:37because there is no way to know after
  • 06:39two years how you have actually traject
  • 06:40changed the trajectory of aging.
  • 06:42You know there are no markers,
  • 06:43there are no biomarkers or
  • 06:44or any of those things.
  • 06:46Anyway,
  • 06:48what we have been interested in is to see if
  • 06:50it is indeed relevant to human Physiology.
  • 06:53Can we harness some of
  • 06:55those endogenous factors?
  • 06:56So this is what happens when people
  • 06:58undergo caloric restriction.
  • 07:00So actually humans in free living
  • 07:02condition can only undergo about
  • 07:0414% or 15% caloric restriction.
  • 07:05The reason why we have obesity
  • 07:07epidemic is because exercise and
  • 07:09reducing food intake doesn't work.
  • 07:10That's why we have pharmacology.
  • 07:12The key point here is that,
  • 07:13so this is transcriptional data
  • 07:15from adipose transcriptome,
  • 07:17data from adipose tissue.
  • 07:18These are individuals at the baseline.
  • 07:20These are individuals
  • 07:21after caloric restriction.
  • 07:22And you can see the remarkable change in
  • 07:24the transcriptome of the adipose tissue.
  • 07:26And I recall that when we were doing
  • 07:28this analysis, my collaborator,
  • 07:29Washu Mike Sardomoff says,
  • 07:30oh, you know,
  • 07:31your mice look amazing.
  • 07:33These are not inbred 99.9%
  • 07:35genetically identical animals.
  • 07:36As far as I know.
  • 07:37They're all human beings.
  • 07:39Yeah. So I'm not going to
  • 07:40go into the detail of that,
  • 07:42but share some really new data
  • 07:45in next 5 minutes or so that is I
  • 07:48think is quite serendipitous in,
  • 07:50in many ways that we have found
  • 07:52suggesting that there are several
  • 07:53other pathways that could be really
  • 07:55interesting and important for weight loss.
  • 07:57So one of the things that we have
  • 07:59been very interested to see is
  • 08:00also the changes in metabolism
  • 08:01that that occurs when individuals
  • 08:03undergo caloric restriction.
  • 08:04So when we did the metabolomics,
  • 08:05the the pathway that really lit up
  • 08:08was the pathway that is associated
  • 08:11with taurine and cysteine metabolism,
  • 08:13which led me into this area that
  • 08:15we had never thought about,
  • 08:17which is the transalphuration path.
  • 08:19Please don't hate me.
  • 08:20This is not meant for you to kind of
  • 08:22really look into it in any details.
  • 08:24We've we've all suffered through TCA cycle.
  • 08:25OK.
  • 08:26The key point here is I want
  • 08:28you to focus on cysteine, OK.
  • 08:30This is a fundamental pathway that is really,
  • 08:33really critical for us in terms of
  • 08:35maintenance of sulfur amino acid metabolism.
  • 08:38OK.
  • 08:38Why is this metabolism showing up
  • 08:40in this calorie restriction we had?
  • 08:42This is not what we predicted and
  • 08:44that's the beauty of science in many ways.
  • 08:46So this is the enzyme just quickly.
  • 08:49So cysteine is made from this
  • 08:52enzyme here cystathione gamma lyase.
  • 08:54And when we checked our transcriptional data,
  • 08:56indeed this enzyme is very
  • 08:58critical and it gets up regulated
  • 09:00upon caloric restriction.
  • 09:02So prediction would be that
  • 09:04you have more cysteine,
  • 09:05well actually just before that
  • 09:08and this increase of this enzyme
  • 09:10while we were doing these studies,
  • 09:11this paper came out from vitamin
  • 09:13Gladyshave's lab that this enzyme is
  • 09:15also increase in multiple intervention
  • 09:17that in in in mice that extend lifespan.
  • 09:20So we thought that OK,
  • 09:21we are probably on the right trajectory,
  • 09:23right.
  • 09:23And and this is the kind of a
  • 09:26snapshot of how cysteine metabolism
  • 09:28and transulphuration looks like.
  • 09:30So this is the methionine cycle.
  • 09:32All of you know that cysteine is
  • 09:34dietary non essential and I'm going to
  • 09:36show you that it's actually really essential.
  • 09:38It may be dietary is not essential,
  • 09:40it's really essential for Physiology.
  • 09:42So this enzyme increases by caloric
  • 09:44restriction and what it does is it
  • 09:47converts histathionine into cysteine.
  • 09:48And as you know cysteine is a very
  • 09:50important substrate for multiple
  • 09:52things including glutathione.
  • 09:53And the key part of cysteine is,
  • 09:55is this very critical modification
  • 09:59here thiol group.
  • 10:00It's the only amino acid that
  • 10:03has a thiol group in it, OK.
  • 10:04And that is absolutely essential
  • 10:06for its function.
  • 10:07But you know,
  • 10:08prediction would be that if the
  • 10:10cysteine levels are high, oh, sorry,
  • 10:12the if the Cth levels are high,
  • 10:14then the cysteine levels are going
  • 10:15to be higher in calorie restriction,
  • 10:17but it's actually the opposite.
  • 10:19So what happens is in individuals
  • 10:21that undergo calorie restriction,
  • 10:22if you measure cysteine levels in the
  • 10:24adipose tissue, it's actually lower.
  • 10:26So Cth is in terms of going up to
  • 10:29kind of maintain the cysteine levels.
  • 10:31So what we decided to do was to see if
  • 10:34we can target CDH and create a artificial
  • 10:37condition of regulating cysteine.
  • 10:39And the way you do that because
  • 10:40if you just restrict cysteine,
  • 10:41it's not going to make any difference because
  • 10:43body is going to make cysteine from CDH.
  • 10:45So what we did was create this mouse.
  • 10:47This work was done by my
  • 10:49former PhD student Eileen Lee.
  • 10:51So she created these animals that
  • 10:53lack Cth enzyme and then restricted
  • 10:55cysteine in the diet.
  • 10:56And what it does is that in this
  • 10:58case there is no cysteine being
  • 11:00made or is either being consumed.
  • 11:02The mice are normal.
  • 11:04Most of these mice in in when
  • 11:06they're in the cysteine.
  • 11:08When you give cysteine in the diet,
  • 11:09they're totally fine.
  • 11:10But notice what happens to the knockouts
  • 11:13when you remove cysteine in the diet,
  • 11:16they undergo massive,
  • 11:17massive weight loss.
  • 11:19And this weight loss,
  • 11:20weight loss is really specific to cysteine.
  • 11:23So if we so this is the weight loss
  • 11:25here with restricting cysteine.
  • 11:27If you put cysteine back in the diet
  • 11:29they gain weight back up and you know
  • 11:32we did this for three cycles just for fun.
  • 11:35These animals don't have disease,
  • 11:37OK,
  • 11:38they don't have malaise.
  • 11:40So these are the knockouts on
  • 11:41cysteine free diet.
  • 11:42They are pretty they are pretty healthy.
  • 11:44So the question is what are these
  • 11:46mice dying of or what is actually
  • 11:48happening in terms of weight loss
  • 11:50because we know that weight loss
  • 11:51can be healthy and UN unhealthy.
  • 11:53What was really striking in
  • 11:55these animals was that when we
  • 11:58depleted cysteine from the system,
  • 12:00what it did was it completely
  • 12:02changed the white adipose tissue
  • 12:05into brown adipose tissue and it
  • 12:07was not like a minor response,
  • 12:08it was total conversion of
  • 12:10the adipose tissue,
  • 12:11both subcutaneous as well as visceral.
  • 12:14All right.
  • 12:15And this is just the marker UCP one,
  • 12:17which is critical for uncoupling.
  • 12:19We all know that mice,
  • 12:20you know they show this response
  • 12:22typically if they're in sub thermal
  • 12:24neutral temperature because our animal
  • 12:25facilities are 22°C whereas you and I,
  • 12:27we all live in thermal neutrality.
  • 12:29So what Eileen did was did the
  • 12:31same experiment in animals that
  • 12:33are kept at 30°C which is thermal
  • 12:35neutral zone and it is independent
  • 12:37of thermal neutrality or cold.
  • 12:39So these animals still lose weight,
  • 12:41dramatic weight loss.
  • 12:42And this weight loss in animals is
  • 12:45considered lethal because they have to
  • 12:47euthanize animals at this point of time.
  • 12:49So idea is what is actually happening.
  • 12:53There is increased energy expenditure
  • 12:55in these in these animals.
  • 12:57So they're expending more energy.
  • 12:59They're eating the same amount of food,
  • 13:01but they're expending more energy.
  • 13:03So we collaborated with Famid
  • 13:05Heider and Daniel Komen here and
  • 13:07and Famid's lab has this fantastic
  • 13:09technique to actually measure
  • 13:11actual temperature in the
  • 13:12brown adipose tissue using a probe which
  • 13:15with with which you can actually measure
  • 13:17the proton relaxation and the proton
  • 13:19leak and and you can actually measure
  • 13:21temperature that way in a very precise way.
  • 13:24And you can see that the there's the brown
  • 13:26adipose tissue in this case is indeed hot.
  • 13:28So I will summarize what we have which is
  • 13:30so this is the transalphuration pathway,
  • 13:32this is what is happening.
  • 13:33So when we get rid of cysteine,
  • 13:35when you deplete cysteine,
  • 13:37what you do is you always have this case,
  • 13:40this loss of cysteine which is
  • 13:42associated with loss of glutathione
  • 13:44and then cysteine and also go into
  • 13:47different pathways that are noted here.
  • 13:49But what happens when you completely
  • 13:51get rid of cysteine in this in in the
  • 13:54animals is activation of this arm which
  • 13:56had previously not been studied in
  • 13:58great detail which leads to formation
  • 14:00of this gamma glutamil peptides.
  • 14:01I don't have time to go into that.
  • 14:03The question you would ask is,
  • 14:04is this dependent on UCP one?
  • 14:05Because UCP one has been thought
  • 14:07to be the Holy Grail of energy
  • 14:10expenditure and the answer is no.
  • 14:12OK, so so we created animals that
  • 14:15lack Cth as well as UCP one,
  • 14:18There's really no response if
  • 14:19you if you don't have UCP one,
  • 14:21the animals brown, they lose weight,
  • 14:22they die.
  • 14:25So how does it actually work?
  • 14:27What happens is that when you deplete
  • 14:29cysteine you get the activation
  • 14:30of sympathetic nervous system,
  • 14:32you get increase in norepinephrine
  • 14:33shown here in the red bar and if
  • 14:36you block norepinephrine receptors
  • 14:37beta 3 adenergic receptor by this
  • 14:41compound L70 four in the blue,
  • 14:43you can protect the animal's
  • 14:44death from the weight loss.
  • 14:46I'll end by just showing you
  • 14:48last pieces of data which is pre
  • 14:50clinical data in animal models
  • 14:51which is fine we're killing animals,
  • 14:54normal animals with by disrupting
  • 14:56this key pathway which.
  • 14:58But the question really is whether
  • 15:00this can be potentially be
  • 15:01harnessed in terms of therapy.
  • 15:03And here are animals that
  • 15:05were fed high fat diet.
  • 15:07These animals are fed high
  • 15:08fat diet for eight weeks.
  • 15:09Then we switched the high fat diet into
  • 15:12high fat diet that only lacks cysteine,
  • 15:15OK.
  • 15:15And they consume same amount of calories.
  • 15:17And what you get is again a dramatic 30%
  • 15:20weight loss within seven days actually.
  • 15:23All right.
  • 15:23And this is associated again
  • 15:26with this massive Browning
  • 15:28of the of the adipose tissue.
  • 15:31So what we ended up discovering in
  • 15:34a way serendipitously through this
  • 15:36study that was initiated in humans
  • 15:39is that the cysteine is actually
  • 15:42critical thermogenic checkpoint.
  • 15:44And if you get rid of cysteine,
  • 15:45the body tries to keep cysteine
  • 15:47because if you get rid of it,
  • 15:48you get this uncontrolled energy expenditure.
  • 15:51So in a normal situation,
  • 15:53you're consuming a cysteine in
  • 15:55your diet and this is required
  • 15:57for your normal energy storage.
  • 15:58You don't really get engagement
  • 16:00of trans sulfuration pathway.
  • 16:02OK, because you're consuming cysteine,
  • 16:03you don't need to make cysteine.
  • 16:05However, if you create an artificial
  • 16:08situation where trans alteration is required,
  • 16:12what you get in this case is this is
  • 16:14the methionine cycle and when the
  • 16:16cysteine levels go down, it triggers.
  • 16:18We don't actually know
  • 16:19exactly how it triggers this.
  • 16:21This loss of cysteine is sensed by
  • 16:23the nervous system in a way that
  • 16:25basically increases sympathetic tone,
  • 16:26it increases Browning,
  • 16:27there is increased proton leak and
  • 16:30heat production in these animals.
  • 16:32It's UCP one independent.
  • 16:34And this is basically,
  • 16:35you know, how it works. So.
  • 16:39So what I've told you is that the
  • 16:41defense of cysteine actually is
  • 16:42absolutely critical and I think
  • 16:44is a thermogenic checkpoint.
  • 16:46And this is the,
  • 16:47as far as I know,
  • 16:48the only study that I know in the
  • 16:49literature where you can actually
  • 16:51kill a mouse by lethal thermogenesis.
  • 16:52OK, so I've shown you that cysteine
  • 16:55starvation causes uncontrolled Browning.
  • 16:57If you get rid of cysteine,
  • 16:58it causes uncontrolled Browning
  • 16:59and the trans alphuration pathway
  • 17:02which is activated in color
  • 17:04illustration is actually a way for
  • 17:06the body to conserve energy.
  • 17:07So obviously the future this is just
  • 17:10you know really emerging work which
  • 17:12we are very interested and excited by
  • 17:14and will time will tell how far this
  • 17:16goes in terms of clinical translation.
  • 17:19All this work was done by Eileen Lee,
  • 17:20a graduate student in the lab.
  • 17:22This project is now being LED
  • 17:24very ably by Lucy Urliegue and
  • 17:25and Abby Lee in the lab and and
  • 17:28of course all my collaborators.
  • 17:30I'm not as organized as Tomas to finish
  • 17:33on time. Sorry.
  • 17:42Thank you. Wonderful questions. Please.
  • 17:50No, it does not affect energy
  • 17:53intake. Yeah. Marcelo,
  • 17:58hello. My question is more general and it's
  • 18:01I was wondering if in the in the
  • 18:04trials with these drugs in general if
  • 18:07there is any evidence that so we know
  • 18:11from that there's more brown adipose
  • 18:13tissue in humans presumably in the
  • 18:16winter here or in cold climates versus
  • 18:20people that live in tropical climates.
  • 18:23So in terms of this thermogenic checkpoint,
  • 18:26if there is any evidence that these drugs
  • 18:29and to visit the drugs work more or
  • 18:32less in the winter versus the summer in
  • 18:35the tropics versus in the cold climate,
  • 18:39if there is any, There's so many people.
  • 18:42So if there's any evidence there,
  • 18:44there's some interaction with
  • 18:46the thermogenic checkpoint.
  • 18:48Yeah, I don't know, Marcelo.
  • 18:49I mean this is a question that you
  • 18:51know folks that study thermogenesis
  • 18:52have been asked several,
  • 18:53several times that you know there
  • 18:54are people living in Scandinavia
  • 18:56in an Arctic and are there is
  • 18:57the less incidence of obesity,
  • 18:59there is some association but association
  • 19:01is not causalities but and most of
  • 19:03those times people are still majority
  • 19:04of the times in thermal neutrality.
  • 19:06You know we still are in
  • 19:08thermal neutral condition.
  • 19:09So they're never though these pathways
  • 19:10are never you know kind of activated.
  • 19:13So it's not really clear hopefully in time,
  • 19:20right
  • 19:22expands quite substantially in the
  • 19:27winter. It tells us that even though
  • 19:29we are regulating our climate,
  • 19:30we are not absolutely determinate
  • 19:33otherwise, you know, yeah,
  • 19:35counter regulation for increasing.
  • 19:37So my point is
  • 19:39to see if the cysteine pathway
  • 19:41is potentially affected in there
  • 19:44in the winter. They are taking
  • 19:46some appetite and all the, yeah
  • 19:52are more effective like the
  • 19:54individual that you were studying.
  • 19:56Yeah, gender question. Yeah, potentially.
  • 20:00Yeah, clinically we haven't seen that yet,
  • 20:02but it's something to consider.
  • 20:04One more quick question shot.
  • 20:10Yeah, the bill will work.
  • 20:11The what is what do you think primary
  • 20:15side of action of positive restriction,
  • 20:18whether when wrong type self or
  • 20:20what type self or the mother? Yeah.
  • 20:23So, so Shawn Yang is asking
  • 20:25how does cysteine work?
  • 20:26Where is it acting?
  • 20:28And the answer is complex.
  • 20:30So we have knocked it out in multiple places,
  • 20:33including liver, adipose tissue.
  • 20:35And if you knock it out in specific cells,
  • 20:38there is no effect because cysteine
  • 20:40is so important for the host that
  • 20:44other organs compensate for it.
  • 20:46As far as brain is concerned,
  • 20:47this is a really a great question.
  • 20:49We don't really know.
  • 20:51We only have preliminary evidence
  • 20:53as at this point of time and I
  • 20:55think we are working with Tomasha's
  • 20:56lab to see and Bernardo here,
  • 20:58who's in I guess in the audience
  • 21:00somewhere to see if cysteine
  • 21:02is being sensed in the brain.
  • 21:03If you get rid of cysteine in the brain,
  • 21:04is that the one that is triggering
  • 21:06the sympathetic nervous system
  • 21:08outflow into the adipose tissue?
  • 21:09But yes,
  • 21:10one thing is very clear that that
  • 21:13the lack of cysteine triggers
  • 21:15the upstream sympathetic activity
  • 21:17that basically then leads to the
  • 21:20thermogenic major thermogenic response.
  • 21:22And most of the thermogenic
  • 21:24response is independent of all
  • 21:26the known current currently known
  • 21:28pathways that people have been
  • 21:30publishing in terms of uncoupling.
  • 21:32None of those are involved.
  • 21:35Great.
  • 21:35OK, With that we're going to go ahead and
  • 21:37move into our break. Thank you so much.